GNAS1基因T393C多态性与EGFR突变状态未明复治晚期非小细胞肺癌TKI疗效的关联研究

BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor (EGFR)-activating mutation predicts excellent response to EGFR tyrosine kinase inhibitors (TKIs). However, lung cancer patients are often with unknown EGFR mutation status because there are little tumor specimen to determine. TKIs induce tum...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2014
Materias:
临床研究
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000015/
https://www.ncbi.nlm.nih.gov/pubmed/24758907
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.04.06

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000015/
https://www.ncbi.nlm.nih.gov/pubmed/24758907
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.04.06

Ejemplares similares